禾元生物-U
(688765)
| 流通市值：100.53亿 | | | 总市值：131.42亿 |
| 流通股本：2.73亿 | | | 总股本：3.58亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 261,339,838.79 | 1,022,900,000.35 | 398,724,422.4 | 669,441,252.44 |
| 应收票据及应收账款 | 416,900.52 | 488,072 | 604,642 | 445,580.04 |
| 应收账款 | 416,900.52 | 488,072 | 604,642 | 445,580.04 |
| 预付款项 | 6,763,878.96 | 8,098,842.37 | 12,837,530.98 | 9,203,554.56 |
| 其他应收款合计 | 1,239,522.24 | 996,820.26 | 976,172.33 | 1,787,416.23 |
| 存货 | 283,085,016.66 | 242,180,084.86 | 146,843,752.19 | 119,320,810.95 |
| 其他流动资产 | 1,215,100,541.12 | 606,280,070.21 | 1,317,826,654.54 | 1,361,904,205.86 |
| 流动资产合计 | 1,767,945,698.29 | 1,880,943,890.05 | 1,877,813,174.44 | 2,162,102,820.08 |
| 非流动资产: | | | | |
| 固定资产 | 542,889,192.07 | 554,191,561.16 | 563,252,843.42 | 574,828,055.98 |
| 在建工程 | 1,405,487,061.94 | 1,218,008,574.24 | 993,709,736.03 | 602,789,246.59 |
| 使用权资产 | 88,635,897.3 | 91,988,458.7 | 83,994,965.42 | 86,279,900.59 |
| 无形资产 | 82,466,548.76 | 83,117,264.81 | 83,767,980.86 | 84,418,696.91 |
| 长期待摊费用 | 14,445,389.16 | 18,162,297.82 | 2,756,176.47 | 2,938,655.12 |
| 其他非流动资产 | 1,999,030.6 | 4,174,432.76 | 35,937,606.23 | 189,530,928.66 |
| 非流动资产合计 | 2,135,923,119.83 | 1,969,642,589.49 | 1,763,419,308.43 | 1,540,785,483.85 |
| 资产总计 | 3,903,868,818.12 | 3,850,586,479.54 | 3,641,232,482.87 | 3,702,888,303.93 |
| 流动负债: | | | | |
| 短期借款 | 4,002,800 | 4,002,800 | - | - |
| 应付票据及应付账款 | 623,080,108.93 | 576,197,413.01 | 406,684,285.2 | 370,363,995.11 |
| 应付账款 | 623,080,108.93 | 576,197,413.01 | 406,684,285.2 | 370,363,995.11 |
| 合同负债 | 31,538,972.52 | 12,932,942.89 | 5,506,889.21 | 2,573,282.6 |
| 应付职工薪酬 | 4,629,442.64 | 4,646,844.16 | 4,500,595.29 | 11,478,117.14 |
| 应交税费 | 1,343,426.07 | 1,039,249.67 | 1,112,971.25 | 2,114,232.27 |
| 其他应付款合计 | 4,690,825.96 | 4,932,901.25 | 6,208,386.32 | 11,880,361.98 |
| 一年内到期的非流动负债 | 23,539,245.18 | 23,451,224.22 | 141,700,179.66 | 55,058,696.31 |
| 其他流动负债 | 67,999.16 | 54,671.79 | 701,164.69 | 128,582.64 |
| 流动负债合计 | 692,892,820.46 | 627,258,046.99 | 566,414,471.62 | 453,597,268.05 |
| 非流动负债: | | | | |
| 长期借款 | 263,461,869.25 | 263,710,869.25 | 98,935,600 | 243,915,436.41 |
| 租赁负债 | 77,571,291.24 | 76,888,425.68 | 69,770,720.82 | 69,353,855.97 |
| 预计负债 | - | - | 1,485,066.89 | 1,485,066.89 |
| 递延收益 | 67,520,878.69 | 39,013,413.96 | 36,022,845.17 | 36,645,652.09 |
| 非流动负债合计 | 408,554,039.18 | 379,612,708.89 | 206,214,232.88 | 351,400,011.36 |
| 负债合计 | 1,101,446,859.64 | 1,006,870,755.88 | 772,628,704.5 | 804,997,279.41 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 357,500,000 | 357,500,000 | 357,500,000 | 357,500,000 |
| 资本公积 | 3,559,213,087.52 | 3,557,370,505.59 | 3,555,547,951.72 | 3,548,789,265.92 |
| 未分配利润 | -1,114,291,129.04 | -1,071,154,781.93 | -1,044,444,173.35 | -1,008,398,241.4 |
| 归属于母公司股东权益合计 | 2,802,421,958.48 | 2,843,715,723.66 | 2,868,603,778.37 | 2,897,891,024.52 |
| 股东权益合计 | 2,802,421,958.48 | 2,843,715,723.66 | 2,868,603,778.37 | 2,897,891,024.52 |
| 负债和股东权益合计 | 3,903,868,818.12 | 3,850,586,479.54 | 3,641,232,482.87 | 3,702,888,303.93 |
| 公告日期 | 2026-10-28 | 2026-08-27 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |